Font Size: a A A
Keyword [TKIs]
Result: 41 - 60 | Page: 3 of 10
41. Caveolin-1 Decreases The Sensibility To TKIs In Non-small Cell Lung Cancer Harboring EGFR Mutations
42. EGFR-TKIs Reduced The Expressions Of CD44/Integrin And Inhibited The Metastasis Mechanism Of Lung Cancer
43. The Effect Of Filamin A On The Sensitivity To TKIs In Non-small Cell Lung Cancer With EGFR Mutations
44. The Cytogenetic And Targeted Treatment Study Of Chronic Myeloid Leukemia
45. Comparing Overall Survival Between First Generation EGFR-TKIs And Chemotherapy In Lung Cancer Patients With Del19/L858R: A Meta-analysis
46. The Role Of EMT In The Acquired Resistance Of Non-small Cell Lung Cancer To EGFR-TKIs And Associated Mechanisms
47. Small Molecular TKIs Versus Chemotherapy In EGFR Mutation-Negative, Previously Treated Non-Small-Cell Lung Cancer-meta-analysis
48. Efficacy And Safety Of Addition Of VEGFR-TKIs To Cytotoxic Chemotherapy In (?)etastatic Breast Cancer:a Meta-analysis
49. Design, Synthesis And Biological Activity Evaluation Of EGFR Inhibitors In Non-small Cell Lung Cancer
50. To Investigate The Clinical Significance Of Epidermal Growth Facter Gege Mutation In Non-Cell Lung Cancer
51. WB-308, A Novel Inhibitor Of EGFR, Suppresses The Growth Of Non-small Cell Lung Cancer (NSCLC)
52. The Design Of Benzyl Ether EGER Inhibitors For The Non Small Cell Lung Cancer, Synthesis And Activity Studies
53. TOPK Promotes Resistance To EGFR Tyrosine Kinase Inhibitors By Phosphorylating And Activating C-Jun In Lung Cancer
54. Analysis On Clinical Effect Of CIK Combined With TKIs In Treatment Of Non-small Cell Lung Cancer Patients With TKIs Resistance
55. Evaluation On Efficacy And Safety Of Radiotherapy Plus EGFR-TKIs In Non Small Cell Lung Cancer With Brain Metastasis: A Meta Analysis
56. Discovery Of A Novel Spliceosome Of ABL Gene(ABLΔexon7+35INS) And The Association With TKIs Resistance In Chronic Myeloid Leukemia
57. The Analysis Of Relevant Factors To Acute Myeloid Leukemia And The Prognostic Indicator Of Chronic Myeloid Leukemia Patients On Treatment With TKIs
58. The Clinical And Molecular Research On Therapeutic Effect Of TKIs In Chronic Myeloid Leukemia
59. The Role Of Cancer Stem Cells In EMT-induced Acquired Resistance To EGFR-TKIs In NSCLC Cells
60. The Clinical Significance Of Subgroups Of T Lymphocyte And Fusion Gene Of BCR/ABLIS Of Chronic Myeloid Leukemia Patients During TKIs Therapy
  <<First  <Prev  Next>  Last>>  Jump to